Lineage Cell Therapeutics Inc. Logo

Lineage Cell Therapeutics Inc.

Develops allogeneic cell therapies from stem cells for degenerative diseases.

LCTX | TA

Overview

Corporate Details

ISIN(s):
US53566P1093
LEI:
Country:
Israel
Address:
Derech Menachem Begin 121, 6701203 Tel Aviv

Description

Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel allogeneic cell therapies for unmet medical needs. The company's proprietary platform uses directed differentiation of pluripotent stem cells to manufacture specialized human cells. These "off-the-shelf" cell transplants are designed to replace or support dysfunctional cells in patients with serious conditions, aiming to restore or enhance physiological function. The therapeutic pipeline is focused on degenerative diseases of the eye, such as dry age-related macular degeneration, and neurological conditions, including spinal cord injury. The company leverages its integrated capabilities in cell line development, manufacturing, and delivery to advance its programs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-28 17:05
8-K
English 50.3 KB
2025-11-24 12:49
8-K
English 50.5 KB
2025-11-15 00:12 English 9.3 KB
2025-11-12 15:25
8-K
English 48.4 KB
2025-11-12 15:15
424B3
English 64.8 KB
2025-11-09 07:46
Immediate Report
English 102.5 KB
2025-11-09 07:46
Immediate Report
English 36.6 KB
2025-11-06 22:18
10-Q
English 1.8 MB
2025-11-06 22:12
8-K
English 155.1 KB
2025-09-26 17:52 English 7.7 KB
2025-09-24 22:39 English 7.2 KB
2025-09-10 23:31 English 7.0 KB
2025-09-08 20:22
Immediate Report
English 30.9 KB
2025-09-08 20:22
Immediate Report
English 36.5 KB
2025-08-26 15:14
8-K
English 135.8 KB

Automate Your Workflow. Get a real-time feed of all Lineage Cell Therapeutics Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Lineage Cell Therapeutics Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Lineage Cell Therapeutics Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.